Nuclear Medicine. Rusatom Healthcare (part of Rosatom) received a registration certificate from the Russian Heath Ministry for the radiopharmaceutical drug Fluorodeoxyglucose, 18-F., which is called the “molecule of the century.” Fluorodeoxyglucose solution is intended for intravenous injection for positron emission tomography (PET). The drug is effective for the early detection and diagnosis of a wide range of cancers.